BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21992804)

  • 21. Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's disease.
    Chen JJ; Liu Q; Yuan C; Gore V; Lopez P; Ma V; Amegadzie A; Qian W; Judd TC; Minatti AE; Brown J; Cheng Y; Xue M; Zhong W; Dineen TA; Epstein O; Human J; Kreiman C; Marx I; Weiss MM; Hitchcock SA; Powers TS; Chen K; Wen PH; Whittington DA; Cheng AC; Bartberger MD; Hickman D; Werner JA; Vargas HM; Everds NE; Vonderfecht SL; Dunn RT; Wood S; Fremeau RT; White RD; Patel VF
    Bioorg Med Chem Lett; 2015 Feb; 25(4):767-74. PubMed ID: 25613679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors.
    Liu J; Chen W; Xu Y; Ren S; Zhang W; Li Y
    Bioorg Med Chem; 2015 May; 23(9):1963-74. PubMed ID: 25842365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.
    Piazzi L; Cavalli A; Colizzi F; Belluti F; Bartolini M; Mancini F; Recanatini M; Andrisano V; Rampa A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):423-6. PubMed ID: 17998161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels.
    Youn K; Yu Y; Lee J; Jeong WS; Ho CT; Jun M
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28869548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The selective BACE1 inhibitor VIa reduces amyloid-β production in cell and mouse models of Alzheimer's disease.
    Cheng X; Zhou Y; Gu W; Wu J; Nie A; Cheng J; Zhou J; Zhou W; Zhang Y
    J Alzheimers Dis; 2013; 37(4):823-34. PubMed ID: 23948917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BACE1 inhibitors: a head group scan on a series of amides.
    Woltering TJ; Wostl W; Hilpert H; Rogers-Evans M; Pinard E; Mayweg A; Göbel M; Banner DW; Benz J; Travagli M; Pollastrini M; Marconi G; Gabellieri E; Guba W; Mauser H; Andreini M; Jacobsen H; Power E; Narquizian R
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4239-43. PubMed ID: 23735744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Officimalonic acids A-H, lanostane triterpenes from the fruiting bodies of Fomes officinalis.
    Han J; Li L; Zhong J; Tohtaton Z; Ren Q; Han L; Huang X; Yuan T
    Phytochemistry; 2016 Oct; 130():193-200. PubMed ID: 27216472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitors.
    Volgraf M; Chan L; Huestis MP; Purkey HE; Burkard M; Geck Do M; Harris J; Hunt KW; Liu X; Lyssikatos JP; Rana S; Thomas AA; Vigers GP; Siu M
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2477-80. PubMed ID: 24780121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of (3S,4S)-4-aminopyrrolidine-3-ol derivatives and biological evaluation for their BACE1 inhibitory activities.
    De Tran Q; Bepary S; Lee GH; Cho H; Park WK; Lim HJ
    Bioorg Med Chem Lett; 2016 Jan; 26(1):51-4. PubMed ID: 26608551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitors.
    Brodney MA; Beck EM; Butler CR; Barreiro G; Johnson EF; Riddell D; Parris K; Nolan CE; Fan Y; Atchison K; Gonzales C; Robshaw AE; Doran SD; Bundesmann MW; Buzon L; Dutra J; Henegar K; LaChapelle E; Hou X; Rogers BN; Pandit J; Lira R; Martinez-Alsina L; Mikochik P; Murray JC; Ogilvie K; Price L; Sakya SM; Yu A; Zhang Y; O'Neill BT
    J Med Chem; 2015 Apr; 58(7):3223-52. PubMed ID: 25781223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1.
    Barrow JC; Rittle KE; Ngo PL; Selnick HG; Graham SL; Pitzenberger SM; McGaughey GB; Colussi D; Lai MT; Huang Q; Tugusheva K; Espeseth AS; Simon AJ; Munshi SK; Vacca JP
    ChemMedChem; 2007 Jul; 2(7):995-9. PubMed ID: 17458843
    [No Abstract]   [Full Text] [Related]  

  • 32. Isolation of cholinesterase and β-secretase 1 inhibiting compounds from Lycopodiella cernua.
    Nguyen VT; To DC; Tran MH; Oh SH; Kim JA; Ali MY; Woo MH; Choi JS; Min BS
    Bioorg Med Chem; 2015 Jul; 23(13):3126-34. PubMed ID: 26003344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosaminoglycans from
    Mycroft-West CJ; Devlin AJ; Cooper LC; Guimond SE; Procter P; Guerrini M; Miller GJ; Fernig DG; Yates EA; Lima MA; Skidmore MA
    Mar Drugs; 2021 Apr; 19(4):. PubMed ID: 33916819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis.
    Azimi S; Zonouzi A; Firuzi O; Iraji A; Saeedi M; Mahdavi M; Edraki N
    Eur J Med Chem; 2017 Sep; 138():729-737. PubMed ID: 28728105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of biphenylacetamide-derived inhibitors of BACE1 using de novo structure-based molecular design.
    Mok NY; Chadwick J; Kellett KA; Casas-Arce E; Hooper NM; Johnson AP; Fishwick CW
    J Med Chem; 2013 Mar; 56(5):1843-52. PubMed ID: 23374014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iminoheterocycle as a druggable motif: BACE1 inhibitors and beyond.
    Zhu Z
    Trends Pharmacol Sci; 2012 May; 33(5):233-40. PubMed ID: 22480948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of key compounds isolated from Corni fructus on BACE1 Activity.
    Youn K; Jun M
    Phytother Res; 2012 Nov; 26(11):1714-8. PubMed ID: 22407769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From AChE to BACE1 inhibitors: The role of the amine on the indanone scaffold.
    Rampa A; Mancini F; De Simone A; Falchi F; Belluti F; Di Martino RM; Gobbi S; Andrisano V; Tarozzi A; Bartolini M; Cavalli A; Bisi A
    Bioorg Med Chem Lett; 2015 Jul; 25(14):2804-8. PubMed ID: 26003339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
    Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
    J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of highly active Alzheimer's beta-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stability.
    Kimura T; Shuto D; Hamada Y; Igawa N; Kasai S; Liu P; Hidaka K; Hamada T; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2005 Jan; 15(1):211-5. PubMed ID: 15582441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.